Featured Research

from universities, journals, and other organizations

Platelet-rich plasma treatment more effective than cortisone for severe hip bursitis

Date:
March 14, 2014
Source:
American Academy of Orthopaedic Surgeons
Summary:
Platelet-rich plasma injections are significantly more effective and durable than cortisone injections for the treatment of severe chronic hip bursitis, according to new research. Chronic hip bursitis is a common yet difficult condition to treat successfully.

Chronic hip bursitis is a common yet difficult condition to treat successfully. A recent study compared the results of PRP and cortisone injections in patients with severe chronic hip (greater trochanteric) bursitis.

Related Articles


In the study, "Platelet-Rich Plasma (PRP) More Effective than Cortisone for Severe Chronic Hip Bursitis," 40 patients were selected for the study and randomly divided into two groups: one group was treated with a single injection of 40 milligrams (mg) of methylprednisolone, and the second group, a single injection of PRP.

Results were recorded using the Harris Hip Score (HHS), which assesses a patient's functionality before and after hip treatment; and the Western Ontario and McMaster Universities Arthritis Index (WOMAC), which measures pain, stiffness and functional limitation. Before the injections, the first group of patients had average HHS scores of 50.5 and WOMAC scores of 58.3, while the second group had similar scores of 51.7 (HHS) and 58.8 (WOMAC). After three months, the cortisone patients reported an average HHS score of 75.3 and a WOMAC score of 83.6; and the PRP patients, 84.2 (HHS) and 91.4 (WOMAC). The PRP patient scores remained high (87.4 HHS, 89.3 WOMAC), while the cortisone patient scores fell to near pretreatment levels (58.8 HHS, 63.4 WOMAC), at one year post treatment.

According to the study authors, PRP injections are significantly more effective and durable than cortisone injections for the treatment of severe chronic hip bursitis.


Story Source:

The above story is based on materials provided by American Academy of Orthopaedic Surgeons. Note: Materials may be edited for content and length.


Cite This Page:

American Academy of Orthopaedic Surgeons. "Platelet-rich plasma treatment more effective than cortisone for severe hip bursitis." ScienceDaily. ScienceDaily, 14 March 2014. <www.sciencedaily.com/releases/2014/03/140314093747.htm>.
American Academy of Orthopaedic Surgeons. (2014, March 14). Platelet-rich plasma treatment more effective than cortisone for severe hip bursitis. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/2014/03/140314093747.htm
American Academy of Orthopaedic Surgeons. "Platelet-rich plasma treatment more effective than cortisone for severe hip bursitis." ScienceDaily. www.sciencedaily.com/releases/2014/03/140314093747.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Liberia Releases Last Ebola Patient, But Threat Remains

Liberia Releases Last Ebola Patient, But Threat Remains

Newsy (Mar. 5, 2015) Liberia&apos;s last Ebola patient has been released, and the country hasn&apos;t recorded a new case in a week. However, fears of another outbreak still exist. Video provided by Newsy
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins